Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN)

In trading today, shares of Nervgen Pharma Corp opened at $2.93 and closed at $2.92. It traded at a low of $2.85 to a high of $2.98.

Shares gained 0.69 percent from the previous day's close of $2.90.

During the day across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 65,463 shares was traded during the session, with total trades of 144, with an average volume of 54,583 over 5 days.

The TSX-V overall saw 1,249 price advancers against 3,959 declines and 110 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have advanced 69.77 percent, while this year, they have advanced 8.15%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $202.79 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..